$CADL

Candel Therapeutics, Inc. (CADL): Submission of Matters to a Vote of Security Holders

Candel Therapeutics, Inc. (CADL) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. 8-K 0001841387 false 0001841387 2026-06-23 2026-06-23 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 23,

Original reporting
Published Jun 24, 2026, 8:24 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 24, 2026, 8:29 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefCorporate actions
Primary signal
$CADL
Neutral
high confidence
Mentioned
$CADL
Relevance
6/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$CADLNeutralLow
01

Why it matters

This is a confirmation of shareholder voting outcomes (director elections and auditor ratification) rather than a new business development.

02

Market read

Traders typically treat this as low-signal governance housekeeping unless tied to a contested proxy, auditor change, or other material event (none described here).

03

What to watch

The proxy statement details are referenced but not included here; any material changes would need to be checked in the April 29, 2026 definitive proxy.

Relevance 6/10Novelty 2/10Timing: Filed after the June 23, 2026 annual meeting results (June 24, 2026 filing).

Background

The company’s Form 8-K (Item 5.07) reports matters voted on at its June 23, 2026 annual meeting, referencing its April 29, 2026 definitive proxy statement.

Company-level read

Ticker impact

$CADLNeutralHigh confidence
Context

Candel Therapeutics filed an 8-K confirming Annual Meeting results: four Class II directors elected and KPMG ratified for FY2026.

Expected impact

Limited near-term impact; any reaction likely muted unless investors were focused on board/accounting changes.

Evidence & confidence

The filing reports voting tallies and ratification of the auditor, without changes to guidance, trials, financing, or enforcement.

Market effects

No sector read-through; governance/auditor ratification is broadly non-informative for biotech fundamentals.

None indicated.

None indicated.

Counterpoint

If investors were specifically concerned about auditor continuity or board composition, the ratification/election could reduce perceived governance risk, but the filing provides no new risk event.

Key entities

  • Candel Therapeutics, Inc.

    Subject of the SEC 8-K; reported annual meeting voting results and auditor ratification.

  • KPMG LLP

    Ratified as independent registered public accounting firm for fiscal year ending Dec. 31, 2026.

Related articles

$SKHYMed

SK Hynix’s $38 billion buildout has a name attached: Nvidia

SK Hynix (SKHY) approved about 54.3 trillion won (about $38.3B) for two memory plants through 2031, Reuters reported. About 35.2 trillion won funds a DRAM fab in Yongin (Y2) with construction starting July 2027 and first cleanroom June 2029. Remaining 19.1 trillion won supports a NAND plant in Cheongju. Reuters also said it is reviewing further shareholder returns.

$ITWMed

Illinois Tool Works Authorizes $6 Bln Buyback

Illinois Tool Works (ITW) said its board authorized a new share repurchase program of up to $6 billion. The board also approved a 7% increase in its regular annual cash dividend to $6.88 per share, effective with the Q4 dividend of $1.72 payable Oct. 9, 2026. ITW closed at $296.66 on Friday.

$JNJMed

Money talcs: Why J&J offered $5.5bn to end cancer cases

Johnson & Johnson is offering $5.5 billion to settle most of more than 70,000 pending talc-related cancer lawsuits, according to the company. Claims allege ovarian cancer or mesothelioma linked to asbestos-contaminated talc. J&J denies wrongdoing and says cases lack merit. Prior orders include $966m (LA) and $1.5bn (Baltimore), with appeals planned.

$AAPLMed

Trump Tariff Refunds Just Topped $100 Billion, and These Companies Are Receiving Some of the Largest Checks

The U.S. Supreme Court invalidated Trump IEEPA tariffs, leaving the administration to refund about $166 billion. By Aug. 4, refunds exceeded $100 billion. Apple received $2.19 billion, Amazon $600 million, and others including Walmart ($2.4B), Ford ($1.3B), GM ($500M), and Costco (~$2B) are expected to receive large checks. New Section 301 tariffs may affect prices.

$MTZMed

Is MasTec’s Debt Raise and Upgraded Guidance Altering The Investment Case For MasTec (MTZ)?

MasTec (MTZ) completed a $647.76 million fixed-rate senior unsecured notes offering with a 5.85% coupon due Sept. 30, 2036. The company reported Q2 2026 sales of $4,373.55 million and net income of $130.12 million, and raised full-year 2026 revenue guidance to $18.2 billion and GAAP net income to $539 million, citing balance-sheet flexibility and governance updates.